Rasagiline Tablet 0.5 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily, as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If well tolerated but the clinical response is insufficient, the dose may be increased to 1 mg once daily. This medicine may be taken with or without food.

This drug should not be administered to certain patients. For example, it should not be used in patients with allergies to any of its ingredients, those currently taking or who have recently discontinued other MAO inhibitors, and those taking pethidine, tramadol, or dextromethorphan. Additionally, it should not be administered in patients with moderate to severe liver dysfunction. Various adverse reactions may occur while taking this medication. Commonly reported side effects include headache, dizziness, nausea, insomnia, myalgia, arthralgia, rash, and orthostatic hypotension, while more severe cases may present serious renal issues or psychiatric symptoms. Caution should be exercised particularly in Parkinson's disease patients, as hallucinations, confusion, and movement disorders may emerge. This drug may impact blood pressure, and excessive consumption of foods high in tyramine poses a risk for rapid blood pressure increases. This medication has a high potential for interaction with other drugs; thus, it should especially not be taken in conjunction with other MAO inhibitors, antidepressants, sympathomimetics, pethidine, tramadol, or dextromethorphan. Additionally, caution is warranted as it can raise blood levels when combined with medications that inhibit the CYP1A2 enzyme. During pregnancy or lactation, the use of this medication requires caution and consultation with a professional since it may affect breastfeeding. The safety of this drug in pediatric patients under 18 years old has not been established; therefore, its use is not recommended. This drug may affect driving skills or machinery operation, so if drowsiness or sudden sleep occurs while taking it, these activities should be avoided. Serious side effects may occur in case of overdose, thus adherence to the prescribed dosage is essential, and immediate medical attention should be sought in case of overdose. Finally, this medication should be stored out of reach of children, maintained at a temperature between 1 and 25 degrees Celsius, and transferring into other containers should be avoided.

• influenza
• skin cancer
• leukopenia
• allergy
• loss of appetite
• depression
• hallucination
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a sealed container to avoid exposure to air and moisture, and it is safest to keep it at room temperature between 1 and 25 degrees Celsius. Therefore, to maintain the drug's efficacy, it is crucial to avoid direct sunlight and high temperatures while storing it appropriately.

Appearance

Flat round tablets with edges that are white or nearly white

Package unit

30 tablets per bottle